4-Bromo-3,5-dimethoxyamphetamine

4-Bromo-3,5-dimethoxyamphetamine
Names
	Preferred IUPAC name 1-(4-Bromo-3,5-dimethoxyphenyl)propan-2-amine
	Other names 4-Bromo-3,5-dimethoxyamphetamine; 2-(4-Bromo-3,5-dimethoxy-phenyl)-1-methyl-ethylamine; 2-(4-Bromo-3,5-dimethoxyphenyl)ethan-1-methyl-amine
Identifiers
CAS Number	32156-34-6 ;
3D model (JSmol)	Interactive image; Interactive image;
ChEMBL	ChEMBL104362 ;
ChemSpider	180279 ;
PubChem CID	208044;
UNII	5BN3H3UZ8R ;
CompTox Dashboard (EPA)	DTXSID30276857 ;
	InChI InChI=1S/C11H16BrNO2/c1-7(13)4-8-5-9(14-2)11(12)10(6-8)15-3/h5-7H,4,13H2,1-3H3 Key: FAVLJTSHWBEOMA-UHFFFAOYSA-N ; InChI=1/C11H16BrNO2/c1-7(13)4-8-5-9(14-2)11(12)10(6-8)15-3/h5-7H,4,13H2,1-3H3 Key: FAVLJTSHWBEOMA-UHFFFAOYAG;
	SMILES C1=C(C(=C(C=C1CC(C)N)OC)Br)OC; Brc1c(OC)cc(cc1OC)CC(N)C;
Properties
Chemical formula	C11H17BrNO2
Molar mass	275.166 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

4-Bromo-3,5-dimethoxyamphetamine (4-Br-3,5-DMA) is a lesser-known psychedelic drug and a substituted amphetamine. It was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 4–10 mg and the duration is listed as 8–12 hours. It produces analgesia, numbness, and reduction of physical feeling. Very little data exists about its pharmacological properties, metabolism, and toxicity.